Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 49, Issue 74, Pages 8187
Publisher
Royal Society of Chemistry (RSC)
Online
2013-08-06
DOI
10.1039/c3cc45220d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones
- (2013) Lourdes Castañeda et al. TETRAHEDRON LETTERS
- Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
- (2013) Felix F. Schumacher et al. Scientific Reports
- Therapeutic application of monoclonal antibodies in cancer: advances and challenges
- (2012) H. Modjtahedi et al. BRITISH MEDICAL BULLETIN
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Antibody–drug conjugates – a perfect synergy
- (2012) John R Adair et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
- (2011) Felix F. Schumacher et al. BIOCONJUGATE CHEMISTRY
- Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
- (2011) Chris P. Ryan et al. CHEMICAL COMMUNICATIONS
- Investigational antibody drug conjugates for solid tumors
- (2011) Puja Sapra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
- (2010) Mark E. B. Smith et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search